Lepu Medical Technology (Beijing) Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

1,569.32

1,633.15

1,736.23

1,317.80

1,401.59

1,441.71

1,897.68

Other Operating Income

0.00

Total Operating income

1,569.32

1,633.15

1,736.23

1,317.80

1,401.59

1,441.71

1,897.68

Raw Material Cost

563.49

670.19

715.19

712.18

677.11

643.80

708.84

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

45.16

43.84

44.73

52.80

41.03

44.96

42.21

Selling and Distribution Expenses

434.08

363.72

388.23

739.54

407.43

456.50

423.19

Other Expenses

15.41

12.25

13.34

13.73

13.75

9.19

13.33

Total Expenditure (Excl Depreciation)

1,196.86

1,200.29

1,281.53

1,641.86

1,263.07

1,237.16

1,307.51

Operating Profit (PBDIT) excl Other Income

372.5

432.9

454.7

-324.09999999999997

138.5

204.60000000000002

590.2

Other Income

47.20

2.58

59.78

-4.24

63.32

61.86

71.97

Operating Profit (PBDIT)

400.89

588.60

666.33

-393.05

355.06

408.12

821.60

Interest

45.16

43.84

44.73

52.80

41.03

44.96

42.21

Exceptional Items

-1.52

-3.23

0.94

-51.36

-18.38

3.76

3.42

Gross Profit (PBDT)

1,005.83

962.96

1,021.04

605.62

724.48

797.91

1,188.84

Depreciation

0.00

177.28

168.45

159.79

Profit Before Tax

354.20

364.24

445.25

-665.66

127.21

207.14

623.03

Tax

33.54

42.09

87.69

-91.09

13.54

-8.43

114.45

Provisions and contingencies

0.00

Profit After Tax

291.13

312.39

378.54

-555.72

105.41

215.37

481.87

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

291.13

312.39

378.54

-555.72

105.41

215.37

481.87

Share in Profit of Associates

0.00

Minority Interest

5.50

9.77

-1.33

-30.34

-12.07

-18.12

10.89

Other related items

0.00

Consolidated Net Profit

296.63

322.15

377.21

-586.05

93.34

197.25

492.76

Equity Capital

0.00

Face Value

1.0

Reserves

16,033.83

15,796.89

15,615.83

15,201.42

15,797.28

15,891.00

16,377.67

Earnings per share (EPS)

0.16

0.17

0.21

-0.3

0.06

0.12

0.26

Diluted Earnings per share

0.16

0.17

0.21

-0.3

0.06

0.12

0.26

Operating Profit Margin (Excl OI)

22.54%

25.03%

24.72%

-42.29%

8.8%

12.93%

31.08%

Gross Profit Margin

22.57%

33.16%

35.86%

-37.73%

21.09%

25.45%

41.25%

PAT Margin

18.55%

19.13%

21.8%

-42.17%

7.52%

14.94%

25.39%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 11.96% vs -28.41% in Sep 2024

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 217.90% vs -76.97% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 21.25% vs -51.31% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is 10.24% vs 9.33% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Lepu Medical Technology (Beijing) Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

1,569.32

Other Operating Income

0.00

Total Operating income

1,569.32

Raw Material Cost

563.49

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

45.16

Selling and Distribution Expenses

434.08

Other Expenses

15.41

0.00

15.41

Total Expenditure (Excl Depreciation)

1,196.86

Operating Profit (PBDIT) excl Other Income

372.46

0.00

372.46

Other Income

47.20

Operating Profit (PBDIT)

400.89

Interest

45.16

Exceptional Items

-1.52

Gross Profit (PBDT)

1,005.83

Depreciation

0.00

Profit Before Tax

354.20

Tax

33.54

Provisions and contingencies

0.00

Profit After Tax

291.13

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

291.13

Share in Profit of Associates

0.00

Minority Interest

5.50

Other related items

0.00

Consolidated Net Profit

296.63

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

16,033.83

Earnings per share (EPS)

0.16

Diluted Earnings per share

0.16

Operating Profit Margin (Excl OI)

22.54%

0.00

22.54%

Gross Profit Margin

22.57%

0.00

22.57%

PAT Margin

18.55%

0.00

18.55%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 156.93 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -3.91% vs -5.93% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 11.96% vs -28.41% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 29.66 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -7.95% vs -14.58% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 217.90% vs -76.97% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 35.37 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -39.64% vs -3.38% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 21.25% vs -51.31% in Sep 2024

Quarterly - Interest

Interest 4.52 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 3.20% vs -2.01% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 10.24% vs 9.33% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 22.54%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024